In the contemporary world pharmaceuticals have become a go-to answer to a growing number of questions. This process of pharmaceuticalization gives rise to a concern with the increasing influence of the pharmaceutical industry on physicians' decision-making. Critics suggest that companies' for-profit-interests might compromise the integrity of medical practice. This article employs qualitative research methodology to explore how Russian physicians deal with the industry's efforts to expand and shape the use of pharmaceuticals. By bridging perspectives of social studies of science and sociology of professions, we offer a contextualized account of physicians' daily practices and interpretations related to pharmaceuticalization. The findings question conventional assumptions of physician-industry relations and allow to delineate a new form of medical professionalism that emerges in the context of pharmaceuticalization and cannot be reduced to either "resisting" industry marketing activities or "giving in" to them and thus corrupting biomedical expertise. Instead, the ways in which physicians navigate abundant sources of knowledge and use industry resources to overcome constraints of their organizational environment attest to mundane forms of agency exercised by physicians in their relations with industry.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714710 | PMC |
http://dx.doi.org/10.1177/13634593221116508 | DOI Listing |
Surg Endosc
January 2025
Department of Surgery, University of Washington, 1959 NE Pacific ST, Box 356410, Seattle, WA, 98115, USA.
Background: It is unknown if there are differential industry payments to surgeons based on gender. This study aims to examine differences by gender for industry relations with minimally invasive surgeons, using speakers at the SAGES Annual Meeting as a proxy for key thought leaders in minimally invasive surgery.
Methods: We queried the Open Payments Database for payments made to US speakers from the 2023 SAGES meeting.
Natl Med J India
August 2024
Department of Pharmacology, Government Polytechnic College, Sant Nagar, Jalandhar 144001, Punjab, India.
Background Physicians and the medical manufacturing industry (MMI) are closely associated and may have some form of financial or business arrangement. Research has highlighted that these interactions negatively impact physicians' prescribing behaviour. We tried to explore medical students' perspectives regarding these interactions.
View Article and Find Full Text PDFOncologist
October 2022
Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: Drug manufacturers claim that the purpose of financial payments to physicians is to facilitate education about new drugs. This claim suggests 2 testable hypotheses: payments should not be associated with drug revenue and payments for each drug should decline over time as physicians become educated.
Materials And Methods: We used open payments data on industry payments.
Health (London)
January 2024
Maastricht University, The Netherlands.
In the contemporary world pharmaceuticals have become a go-to answer to a growing number of questions. This process of pharmaceuticalization gives rise to a concern with the increasing influence of the pharmaceutical industry on physicians' decision-making. Critics suggest that companies' for-profit-interests might compromise the integrity of medical practice.
View Article and Find Full Text PDFPLoS One
November 2021
Global Health Policy and Data Institute, San Diego, CA, United States of America.
The Open Payments database reports payments made to physicians by industry. Given the potential for financial conflicts of interest relating to patient outcomes, further scrutiny of these data is valuable. Therefore, the objective of this study was to analyze physician-industry relationships by specialty type, payment type, geospatial trend, and longitudinal trend between 2014-2018.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!